Free-Cash-Flow Compounders
Top 50 by FCF margin (FY), refreshed hourly from daily closes — and an answer to any stock question.
- Real-time data
- No spam, unsubscribe anytime
- Updated daily
Ask anything about a stock — price, moves, comparisons, 52-week range — answered from price history with sources
Companies that meet two tests at once from their filed annual accounts: free cash flow of at least 15% of revenue in the latest fiscal year, and revenue that has compounded at 10% or more a year over the last five fiscal years. The combination describes a business that is both growing and turning that growth into cash — the profile investors mean when they say "compounder".
How this screen is computed
Free cash flow = net cash from operating activities − payments for property, plant and equipment, both as filed; FCF margin divides that by the same year's revenue. The five-year revenue CAGR compares the latest fiscal year's revenue with the year five fiscal years earlier: (latest ÷ earlier)^(1/5) − 1. All facts come from the SEC's XBRL frames, so they are the audited figures each company reported, not a vendor's normalised version.
Companies missing any of the inputs — no capex tag, no revenue five years back (recent listings), revenue tagged under a concept the loader does not read yet (some financials) — are excluded rather than filled in. The list is ranked by free cash flow in dollars rather than by margin, because a single customer prepayment can print a margin above 100% for one year; the margin column shows the ratio so the two tests can be read together.
How to read it
A high FCF margin with steady growth usually points to pricing power or a capital-light model — software, franchisors, asset managers, some consumer brands. The same screen also catches cyclical businesses at a peak year, when one very good year inflates both the margin and the five-year growth rate; the fiscal-year column and the one-year price move help spot those.
Free cash flow is after maintenance and growth capex alike, so a company investing heavily in new capacity can fail the margin test while being in excellent health, and a company starving its assets can pass it for a while. Neither test says anything about price: a compounder at 60 times free cash flow and one at 15 times are both on this list. The interactive screener lets you add a valuation condition.
Other screens
- Stocks Near Their 52-Week High
- Stocks Near Their 52-Week Low
- Momentum Stocks: Up 10% or More in a Month
- Stocks That Beat Earnings Last Quarter
- Stocks Analysts Are Upgrading
- Dividend Stocks Yielding Over 4%
- Low P/E Stocks: Under 15× Trailing Earnings
- Golden Cross Stocks: 50-Day Above 200-Day
- Oversold Stocks: RSI at or Below 30
- Mega-Cap Stocks: $200 Billion and Above
- Stocks With Insider Buying
- Companies With Net Cash
Important Disclaimer — Not Investment Advice
Disclaimer: This article is provided by Money365.Market for general information and educational purposes only. It is not financial advice, a personal recommendation, or an inducement to buy, sell, or invest in any security or product. Capital is at risk and the value of investments can go down as well as up; past performance does not indicate future results. You should seek independent advice from an FCA-authorised adviser before making any financial decision.
Nothing here is an offer or a solicitation to buy or sell anything, and reading it creates no advisory or fiduciary relationship between you and Money365.Market. Any decision you take is your own.
- You can lose money — including all of it. Individual companies can and do fail, and some of the assets discussed can fall to zero. Only commit money you can afford to lose, and never borrow to invest on the strength of anything you read here.
- Forecasts are opinion, not fact. Any valuation model, scenario, fair-value range, estimate or other forward-looking statement is illustrative, rests on assumptions that may prove wrong, and is never a price target, a forecast of actual outcomes, or a promise of any return.
- Published at a point in time. Figures were believed accurate on the publication or last-updated date shown above and are not maintained afterwards; we are under no obligation to update them. Market and company data comes from third-party sources and is provided without warranty of accuracy, completeness or timeliness.
- We are not regulated. Money365.Market is not authorised or regulated by the UK Financial Conduct Authority, is not registered with the U.S. Securities and Exchange Commission or FINRA as an investment adviser or broker-dealer, and is not a tax adviser. We hold no licence to give personal financial advice and do not do so.
- Interests and independence. Money365.Market is not affiliated with, endorsed by or sponsored by any company, fund, exchange or platform mentioned, and is not paid to feature them. The author may hold positions in securities or assets discussed. The site earns revenue from advertising, subscriptions and, where labelled, affiliate links; this does not influence what we publish.
- Your jurisdiction matters. Tax treatment, contribution limits, product availability and investor protections differ by country and can change. Speak to a qualified tax professional for tax matters, and to a locally licensed adviser if you are outside the UK.
Full terms: Disclaimer · Terms of Service · Privacy Policy